Success Metrics

Active Trials
3(60%)

Phase Distribution

Ph early_phase_1
5
100%

Phase Distribution

5

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
5(100.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Other(2)

Detailed Status

Recruiting3
unknown2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
N/A
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 15 (100.0%)

Trials by Status

recruiting360%
unknown240%

Recent Activity

3 active trials
Showing 5 of 5
recruitingearly_phase_1

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

NCT05961111
unknownearly_phase_1

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

NCT05886075
recruitingearly_phase_1

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors

NCT05860374
recruitingearly_phase_1

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer

NCT05830240
unknownearly_phase_1

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer

NCT05801783

Clinical Trials (5)

Showing 5 of 5 trials
NCT05961111Early Phase 1

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

Recruiting
NCT05886075Early Phase 1

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

Unknown
NCT05860374Early Phase 1

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors

Recruiting
NCT05830240Early Phase 1

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer

Recruiting
NCT05801783Early Phase 1

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5